Pelthos Therapeutics Inc. (PTHS): Insider Trading, Congress Trades & Research | Tormere

PTHS

$21.48+4.78%website ↗⬇ financials (.py)

Pelthos Therapeutics Inc.

Market Cap

$75M

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

3.02

31mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

1.7

Price / TTM revenue

P/B

N/M

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

1.05x

Sell Rate (90d)

23.79/mo

Sell Baseline

58.09/mo

Unique Sellers (90d)

3

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-02	2026-10-06	Pauls Matthew	Director	Sale	786	$21.00	$17K	13.6K	View
2026-10-02	2026-10-06	Greenleaf Peter	Director	Sale	797	$21.17	$17K	23.1K	View
2026-10-02	2026-10-06	Friedberg Ezra M	Director	Sale	558	$20.72	$12K	80.5K	View
2026-07-02	2026-07-07	Friedberg Ezra M	Director	Sale	558	$26.09	$15K	81.0K	View
2026-07-02	2026-07-07	Pauls Matthew	Director	Sale	786	$26.16	$21K	14.4K	View

1–5 of 13

1 / 3

Reporting Insiders

Matthew Pauls
Director
3 transactions · last 2026-10-02
Peter Greenleaf
Director
3 transactions · last 2026-10-02
Ezra M. Friedberg
Director
3 transactions · last 2026-10-02
Ezra M. Friedberg
Director
7 transactions · last 2026-06-15
Knuettel Francis II
CFO, Treas & Secty
1 transaction · last 2026-05-22
Richard Malamut
Director
2 transactions · last 2026-04-02
Matthew Pauls
Director
2 transactions · last 2026-04-02

Recent News

Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares

MarketBeat · 2026-10-06

Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock

MarketBeat · 2026-10-06

Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock

Investing.com · 2026-10-06

Pelthos Therapeutics director sells $11,560 in common stock By Investing.com

Investing.com UK · 2026-10-06

Under a trading plan, Pelthos Therapeutics (PTHS) director sells 797 shares at $21.17.

Stock Titan · 2026-10-06

Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%

Yahoo · 2026-10-06

PTHS PE Ratio & Valuation, Is PTHS Overvalued

Intellectia AI · 2026-10-02

Stockholders elect eight directors as Pelthos Therapeutics (PTHS) adopts its 2026 stock incentive plan.

Stock Titan · 2026-10-01

Pelthos (PTHS) Q2 2026 Earnings Call Transcript

Yahoo Finance · 2026-08-20

Pelthos Therapeutics Q2 Earnings Call Highlights

Yahoo Finance · 2026-08-14

Pelthos Therapeutics Inc (PTHS) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as ...

Yahoo Finance · 2026-08-13

Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary

Yahoo Finance · 2026-08-13

Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates

Yahoo Finance · 2026-08-13

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-13

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Yahoo Finance · 2026-08-03

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-10-02	Pauls Matthew	S	786	$16,506
2026-10-02	Greenleaf Peter	S	797	$16,872.49
2026-10-02	Friedberg Ezra M	S	558	$11,560.03
2026-07-02	Friedberg Ezra M	S	534	$13,900.18
2026-07-02	Friedberg Ezra M	S	24	$655.81